JP2024546844A5 - - Google Patents

Info

Publication number
JP2024546844A5
JP2024546844A5 JP2024535383A JP2024535383A JP2024546844A5 JP 2024546844 A5 JP2024546844 A5 JP 2024546844A5 JP 2024535383 A JP2024535383 A JP 2024535383A JP 2024535383 A JP2024535383 A JP 2024535383A JP 2024546844 A5 JP2024546844 A5 JP 2024546844A5
Authority
JP
Japan
Prior art keywords
approximately
solid form
ray powder
powder diffraction
form according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546844A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081795 external-priority patent/WO2023114995A1/en
Publication of JP2024546844A publication Critical patent/JP2024546844A/ja
Publication of JP2024546844A5 publication Critical patent/JP2024546844A5/ja
Pending legal-status Critical Current

Links

JP2024535383A 2021-12-16 2022-12-16 ピラゾロ[3,4-d]ピリミジン化合物の固体形態 Pending JP2024546844A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163290136P 2021-12-16 2021-12-16
US63/290,136 2021-12-16
PCT/US2022/081795 WO2023114995A1 (en) 2021-12-16 2022-12-16 Solid forms of pyrazolo[3,4-d]pyrimidine compounds

Publications (2)

Publication Number Publication Date
JP2024546844A JP2024546844A (ja) 2024-12-26
JP2024546844A5 true JP2024546844A5 (cg-RX-API-DMAC10.html) 2025-12-04

Family

ID=85172741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535383A Pending JP2024546844A (ja) 2021-12-16 2022-12-16 ピラゾロ[3,4-d]ピリミジン化合物の固体形態

Country Status (11)

Country Link
US (2) US12012412B2 (cg-RX-API-DMAC10.html)
EP (1) EP4448529A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024546844A (cg-RX-API-DMAC10.html)
KR (1) KR20240119299A (cg-RX-API-DMAC10.html)
CN (1) CN118401525A (cg-RX-API-DMAC10.html)
AU (2) AU2022416644B2 (cg-RX-API-DMAC10.html)
CA (1) CA3242577A1 (cg-RX-API-DMAC10.html)
IL (1) IL313314A (cg-RX-API-DMAC10.html)
MX (1) MX2024007517A (cg-RX-API-DMAC10.html)
TW (1) TW202333676A (cg-RX-API-DMAC10.html)
WO (1) WO2023114995A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024546844A (ja) 2021-12-16 2024-12-26 ファイザー・インク ピラゾロ[3,4-d]ピリミジン化合物の固体形態
WO2025043067A2 (en) * 2023-08-22 2025-02-27 Cardurion Pharmaceuticals, Inc. Pyrazolo[3,4-d]pyrimidinone compounds for the treatment of chronic heart failure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
PT2152712E (pt) 2007-05-11 2012-02-29 Pfizer Compostos amino-heterocíclicos
CN109893653A (zh) * 2017-12-11 2019-06-18 王慧敏 Pde9抑制剂的新用途
JP2024546844A (ja) * 2021-12-16 2024-12-26 ファイザー・インク ピラゾロ[3,4-d]ピリミジン化合物の固体形態

Similar Documents

Publication Publication Date Title
JP2022540668A5 (cg-RX-API-DMAC10.html)
JP2015533168A5 (cg-RX-API-DMAC10.html)
FI4157832T3 (fi) Glp-1r-agonistien suola- ja kidemuotoja ja niiden käyttötarkoituksia
CA1155116A (en) Phenyl piperazine derivatives having antiagressive activity
RU2016101964A (ru) СТИМУЛЯТОРЫ sGC
JP2022542803A5 (cg-RX-API-DMAC10.html)
TWI359803B (en) Tetraphenylnaphthalene derivatives and organic lig
JP2025511847A5 (cg-RX-API-DMAC10.html)
JP2023546125A5 (cg-RX-API-DMAC10.html)
JP2024508526A5 (cg-RX-API-DMAC10.html)
RU2014122261A (ru) Форма iv ивабрадина гидрохлорида
CZ302591B6 (cs) 2´-Substituované 1,1´-bifenyl-2-karboxamidy, jejich použití a farmaceutické prostredky, které je obsahují
JP2007533672A5 (cg-RX-API-DMAC10.html)
JP2024502178A5 (cg-RX-API-DMAC10.html)
CA2626451A1 (en) Cyclopropylacetic acid derivatives and use thereof
JPS59118783A (ja) 新規の置換された1,4−ジヒドロピリジン、その製造法及びこれを診断剤として使用する方法
CA2488193A1 (en) Inhibitors of the gpib -vwf interaction, their preparation and use
JP2024514090A5 (cg-RX-API-DMAC10.html)
JP4319148B2 (ja) S−(−)−アムロジピンニコチネート及びその製造方法
JP2022540678A5 (cg-RX-API-DMAC10.html)
US20080293781A1 (en) Salicylic Acid Derivatives
JP2005504795A5 (cg-RX-API-DMAC10.html)
WO2016145622A1 (zh) 苯并咪唑衍生物及其制备方法和医药用途
JP2013540780A (ja) イミダゾール誘導体並びにその製造法及び使用
US4250316A (en) Pyridyl guanidine anti-ulcer agents